BONUS: How Effective Are Antibody Treatments For COVID-19?

The Food and Drug Administration has issued emergency use authorizations for two monoclonal antibody treatments for COVID-19 – one produced by Eli Lilly and another by Regeneron. But emergency use authorization doesn't assure the drugs are effective. In this episode of Short Wave , NPR's daily science podcast, science correspondent Richard Harris explains how the new treatments work — and whether they could really make a difference for patients with COVID-19. Listen to more episodes of Short Wave on Apple Podcasts or Spotify . Learn more about sponsor message choices: podcastchoices.com/adchoices NPR Privacy Policy